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We characterized HIV-1 reverse transcriptase (RT) variants
either with or without the ()-2,3-deoxy-3-thiacytidine-re-
sistant M184I mutation isolated from a single HIV-1 infected
patient. First, unlike variants with wild-type M184, M184I RT
variants displayed significantly reduced DNA polymerase activ-
ity at low dNTP concentrations, which is indicative of reduced
dNTP binding affinity. Second, the M184I variant displayed a
10- to 13-fold reduction in dNTP binding affinity, compared
with the Met-184 variant. However, the kpol values of these two
RTs were similar. Third, unlike HIV-1 vectors with wild-type
RT, the HIV-1 vector harboring M184I RT failed to transduce
cell types containing low dNTP concentrations, such as human
macrophage, likely due to the reduced DNA polymerization
activity of theM184IRTunder low cellular dNTPconcentration
conditions. Finally, we compared the binary complex structures
of wild-type and M184I RTs. The Ile mutation at position 184
with a longer and more rigid -branched side chain, which was
previously known to alter the RT-template interaction, also
appears to deform the shape of the dNTP binding pocket. This
can restrict ground state dNTP binding and lead to inefficient
DNA synthesis particularly at low dNTP concentrations, ulti-
mately contributing to viral replication failure in macrophage
and instability in vivo of the M184I mutation.
()-2,3-Deoxy-3-thiacytidine (3TC),3 a deoxycytidine
analog reverse transcriptase (RT) inhibitor, has been routinely
included in the anti-HIV-1 drug regime (1, 2). During 3TC ther-
apy, two amino acid substitutions at position 184 of RT are
sequentially selected, conferring viral resistance to this drug.
The M184I mutation is detected earlier, and eventually
replaced with theM184Vmutation. One initial explanation for
the delayed selection of the M184V mutation is the require-
ment of two nucleotide mutations to develop the final M184V
mutation from the wild-typemethionine codon (ATG). In con-
trast, the M184I mutation requires only a single nucleotide
mutation from the Met codon, which may result in its early
selection during 3TC therapy (3–7).
Structural analysis later provided a functional explanation
for the instability in vivo of the M184I mutation. The M184I
mutation alters theRT interactionwith the template nucleotide
more significantly than the M184V mutation, leading to more
severely decreased processivity, compared with theM184V RT
(8). Indeed, the distributive DNA synthesis catalyzed by the
M184I RT has been a major explanation for the instability in
vivo of this mutation and its rapid transition to the M184V
mutation. The long -branched side chains of these two muta-
tions efficiently block the entry of 3TCTP to the active site (8,
9). Interestingly, pre-steady-state kinetic studies of the M184V
mutant demonstrated that the M184V mutation only slightly
(1- to 2-fold) affects Kd (dNTP binding affinity), but not kpol
(conformational change/chemical catalysis) steps of HIV-1 RT
with normal dNTP substrates, implying that the Val mutation
does not significantly affect the structural architecture of the
HIV-1 RT dNTP binding pocket (10–12). In addition, the
M184I RT showed a greater fold increase of enzyme fidelity than
theM184VRT,even though theeffectsof themutationson fidelity
are relatively small (13–15). It was also reported that theMet-184
mutations alter the mutation spectrum of HIV-1 RT (13).
The cellular dNTP concentrations of the two HIV-1 target
cells, activated/dividing CD4 T cells and terminally differen-
tiated/non-dividing macrophage, were recently determined.
Macrophage contain very low dNTP concentrations (2040
nM) compared with activated CD4 T cells (4 M) (16). The
extremely low availability of dNTP in macrophage raised a
question about how HIV-1 RT is able to polymerize DNA in
such a low dNTP environment. To address this issue, we
recently examined HIV-1 RT for its dNTP concentration-de-
pendent DNA synthesis profile and kinetic parameters such as
Kd and kpol and compared these with the same parameters for
the RT of MuLV, which replicates only in cells displaying a
mitotic index with high cellular dNTP concentrations (i.e.
dividing cells). Indeed, HIV-1 RT efficiently synthesizes DNA
* This work was supported by Grants AI49781 (to B. K.) and R25GM64133 (to
J. M. S.) from the National Institutes of Health. The costs of publication of
this article were defrayed in part by the payment of page charges. This
article must therefore be hereby marked “advertisement” in accordance
with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Both authors contributed equally to this work.
2 To whom correspondence should be addressed: Dept. of Microbiology and
Immunology, University of Rochester Medical Center, 601 Elmwood Ave.,
Box 672, Rochester, NY 14642. Tel.: 585-275-6916; Fax: 585-473-9573;
E-mail: baek_kim@urmc.rochester.edu.
3 The abbreviations used are: 3TC, ()-2,3-deoxy-3-thiacytidine; HIV-1,
human immunodeficiency virus, type 1; RT, reverse transcriptase; TP, tem-
plate-primer complex; p66, 66-kDa HIV-1 RT polypeptide; MACS, Multi-
center AIDS Cohort Study; DTT, dithiothreitol; MuLV, murine leukemia
virus; SIV, simian immunodeficiency virus; HLF, human lung fibroblast; dN,
deoxynucleoside; pol, polymerase; eGFP, enhancedgreen fluorescent pro-
tein; FACS, fluorescence-activated cell sorting; 3TCTP, 2,3-Dideoxy-3-
thia-cytidine-5-triphosphate.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 283, NO. 14, pp. 9206–9216, April 4, 2008
© 2008 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in the U.S.A.
9206 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 283•NUMBER 14•APRIL 4, 2008
 by guest on A
ugust 22, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
even at low dNTP concentrations corresponding to macro-
phage as well as in high dNTP concentrations found in acti-
vatedCD4Tcells. Conversely,MuLVRT failed to polymerize
DNAat the same lowdNTP concentrations but showed activity
only at high dNTP concentrations found in dividing cells (5
MdNTP) (16). Furthermore,HIV-1RT showed between 6 and
150 times tighter dNTP binding affinity than MuLV RT, sug-
gesting that the high dNTP binding affinity of HIV-1 RT
enables it to polymerize DNA efficiently at low dNTP concen-
trations (17). This unique, efficient dNTP synthesis nature was
also found in RTs of other lentiviruses such as SIV and feline
immunodeficiency virus. In addition, other non-lentiviral RTs
such as avian myeloblastosis virus RT and feline leukemia virus
RT remain active only at high dNTP concentrations found in
dividing cells (16, 18–21).We also observed that twoHIV-1 RT
mutants,Q151NandV148I, whichhave reduceddNTPbinding
affinity, showed high RT activity only at high dNTP concentra-
tions, similar toMuLVRTandother oncoretroviral RTs (16, 22,
23). Importantly, HIV-1 variants harboring these dNTP bind-
ing RT mutants failed to infect macrophage even though these
mutant viruses still efficiently infect cell types with high cellular
dNTP concentrations (16). An HIV-1 vector containing the
Q151N RT was unable to transduce normal dividing cells such
as human lung fibroblasts (HLFs), but efficiently transduced
cancer cell lines containing unusually elevated dNTP concen-
trations due to their uncontrolled cell cycle (24). The failure of
the Q151N HIV-1 vector to transduce HLF was rescued by
deoxynucleoside (dN) treatment,which greatly elevates cellular
dNTP concentration (24). These findings suggest that the
dNTP interactionmechanismofHIV-1RTand the dNTPavail-
ability of virus target cells can contribute to cell type specific
replication and infection of retroviruses.
Here, using M184I HIV-1 RT variants isolated from an
infected patient, we found that the M184I mutation reduces
the dNTP binding affinity of HIV-1 RT, which leads to
decreased RT activity, particularly at low in vivo cellular
dNTP concentrations. This significantly altered dNTP bind-
ing affinity, which was not observed with the M184V HIV-1
RT mutant, may contribute to the in vivo instability and
rapid replacement of the M184I mutation with the M184V
mutation during 3TC therapy.
MATERIALS ANDMETHODS
Isolation and Cloning of HIV-1 RT Variants from an
HIV-1 positive Serum Sample
A serum sample from an HIV-1 infected patient, containing
M184I RT variants, was obtained from the Multicenter AIDS
Cohort Study (MACS, case number 30329), NIAID, National
Institutes of Health. HIV-1 Viral RNA was isolated from the
serum samples using the QIAamp Viral RNAMini kit (Qiagen,
Valencia, CA). The isolated viral RNA genomes were reverse
transcribed to cDNA using a first strand cDNA synthesis kit
(Fermentas, Hanover,MD), which usesM-MuLV as the reverse
transcriptase. The primer used for the first strand cDNA syn-
thesis (HIV INN-terminal reverse primer 5-CACTAGCCAT-
TGCTCTCC-3) was designed using complementary regions
from the pol regions of strains NL4–3 and BRU of HIV-1 RT.
The RT gene was then amplified from cDNA, using pfu DNA
polymerasewith amixture ofN-TForward primers (NL43BRU
Forward primer 5-CCCATTAGTCCTATTGA-3 and HXB2
Forward primer 5-CCCATTAGCCCTATTGA-3) and C-T
Reverse primer (5-CTAAAAATAGTACTTTCCTG-3). After
amplification with pfu polymerase, 3 A overhangs were added
using Taq polymerase. The amplified 1.6-kb product was then
cloned directly to TA cloning vector pCR2.1 (Invitrogen), fol-
lowed by transformation into DH5 (Invitrogen) and plated on
2XYT/Carb/5-bromo-4-chloro-3-indolyl--D-galactopyrano-
side/isopropyl 1-thio--D-galactopyranoside plates for blue-
white selection. Twenty white colonies were screened by EcoRI
digestion (New England Biolabs), and ten isolates positive for
RT inserts were sequenced by the ABI system using M13 for-
ward primer (5-GTAAAACGACGGCCAG-3). Among the
ten RT clones, three RT clones contained the M184I mutation,
and these three also contained 3–4 other mutations through-
out their genomes. The remaining seven clones contained the
wild-type Met residue at the 184 position. Three N-terminal
primers containing an NdeI restriction site (shown in bold)
were designed for cloning RT inserts into bacterial overex-
pression vector, pET28a (Novagen, Madison, WI). The
primer sequences are as follows: N-T NdeI (bold) CG primer
5-AAAAAACATATGCCCATTAGCCCTATTGAGAC-
3, N-T NdeI TA primer 5-AAAAAACATATGCCCATTAG-
TCCTATTGAAAC-3,N-TNdeITGprimer5-AAAAAACAT-
ATGCCCATTAGTCCTATTGAGAC-3. The C-Terminal
reverse primer contains the HindIII site (bold),
5-AAAAAAAAGCTTTTATAGTACTTTCCTGATTCC-3.
Construction of the I184M Revertant RT of theM184I Variant
The Ile to Met (I184M) revertant was cloned using overlap-
ping PCR to achieve site-directed mutagenesis. During the first
round of PCR, N-T NdeI TG forward and IM reverse primer
pairs (to amplify the N-terminal region of RT) and IM forward
and C-T HindIII reverse primer pairs (to amplify the C-termi-
nal region of RT) were used. DNA from M184I RT Clone 7
containing theM184I RTmutationwas used as the template for
this PCR. The second round of PCR was performed using the
N-T NdeI TG forward and C-T HindIII reverse primers. The
primer sequences for IM forward and reverse primers are: 5-
GATGATTTGTATGTAGGATC-3 and 5-GATCCTACAT-
ACAAATCATCGAGTATTGATAGATAAC-3, respectively.
Purification of HIV-1 RT Variants
The RT variants were overexpressed in Escherichia coli BL21
(Novagen) from derivatives of the pET28a-HIV-1 RT plasmid.
The HIV-1 RT expression construct encodes full-length HIV-1
p66 fused at the N terminus to a six-histidine tag, which
facilitates protein purification using a Ni2 chelation chro-
matography according to the manufacturer’s protocol
(Novagen) as described previously (25, 26). From 1 liter of
culture, we were able to purify 4 mg of p66/p66
homodimers with95% purity determined by visual inspec-
tion of Coomassie-stained gels using 99% pure bovine serum
albumin (Sigma, MO). M184V HIV-1 RT protein was puri-
fied from pET28 HIV-1 RT (NL4–3) containing M184V
mutation created by site-directed mutagenesis.
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dNTP Concentration-dependent Reverse Transcription Assay
To measure the ability of RTs to perform DNA synthesis in
the presence of different concentrations of dNTP, template-
primer (TP) was extended using similar activities of RT vari-
ants with dNTP concentrations ranging from 5 to 0.05 M.
Briefly, TP was prepared by annealing a 38-mer RNA template
(5-GCUUGGCUGCAGAAUAUUGCUAGCGGGAAUUCG-
GCGCG-3, Dharmacon Research, Chicago, IL) to a 17-mer “A
primer” (5-CGCGCCGAATTCCCGCT-3; template: primer,
2.5:1) 32P-labeled at the 5-end by T4 polynucleotide kinase
(New England Biolabs) and [-32P]ATP (PerkinElmer Life Sci-
ences). Assay mixtures (20 l) contained 10 nM TP, all four
dNTPs at varying concentrations (5, 1, 0.25, 0.1, and 0.05 M),
25 mM Tris-HCl (pH 8.0), 100 mM KCl, 2 mM DTT, 5 mM
MgCl2, 2 M (dT)20, and 0.1 mg/ml bovine serum albumin.
Reactions were initiated by adding RT activity giving full exten-
sion of 50% of labeled primer at 5 M dNTP incubated at 37 °C
for 5 min and terminated by adding 10 l of 40 mM EDTA and
99% formamide followedby incubation at 95 °C for 5min. Reac-
tions were resolved on 14% polyacrylamide-urea denaturing gel
and then analyzed through phosphorimaging.
3TCTP Sensitivity Assay
Similar to the DNA polymerization assay, 17-mer A primer
was 5-end 32P-labeled using T4 polynucleotide kinase (New
England Biolabs) and [-32P]ATP (PerkinElmer Life Sci-
ences). TP complex was prepared by annealing the 38-mer
RNA (see above) template to the 17-mer A primer. Assay
mixtures (20 l) contained 10 nM TP, RT proteins giving
similar levels of activity (50% primer extension at 5 M
dNTP), all four dNTPs (5 M), 3TCTP (Moravek, CA)
(0–125 M), 25 mM Tris-HCl, pH 8.0, 100 mM KCl, 2 mM
DTT, 5 mMMgCl2, 2 M (dT)20, and 0.1 mg/ml bovine serum
albumin (New England Biolabs). Reactions were incubated at
37 °C for 5 min and terminated by addition of 10 l of 40 mM
EDTA, 99% formamide. Reaction products were immedi-
ately denatured by incubating at 95 °C for 5 min, and reac-
tions were analyzed by electrophoresis on a 14% polyacryl-
amide-urea denaturing gel followed by phosphorimaging.
Pre-steady state Kinetic Assays
Pre-steady state burst and single turnover experiments were
performed to examine the transient kinetics associated with
incorporating a single nucleotide on to primer annealed to a
template. Because these reactions occur within the millisecond
time scale, reactionswere performed using a rapid quench-flow
machine (Kintek, TX).
Pre-steady state Burst Experiments—Pre-steady state burst
experiments were initially performed to determine the concen-
tration of active RT (RT molecules that can bind to and extend
TP) in each protein preparation. For the active site determina-
tion we used 23-mer Primer T (5-CCGAATTCCCGCTAGCA-
ATATTC-3) annealed to a 38-mer DNA template (Dharmacon
Research), 5-GCTTGGCTGCAGAATATTGCTAGCGGGAA-
TTCGGCGCG-3. Reactions were carried out by mixing (a) 150
nM of RT preincubated with 300 nM TP with (b) 800 M dTTP
mixed with 10 mM MgCl2.
Polymerization reactions were quenchedwith 0.3 M EDTA at
time intervals ranging from5ms to 2 s. During this period, a fast
initial burst occurs followed by a slower steady state due to
multiple rounds of extensions. Pre-steady state kinetic data
were analyzed using nonlinear regression. Equations were gen-
erated from the data with the KaleidaGraph, version 3.51 (Syn-
ergy Software, Essex Junction, VT). Data points obtained dur-
ing the burst experiment were fitted to the burst equation
(Equation 1) (27, 28).
Product A1 expkobst	 ksst	 (Eq. 1)
The value A is the amplitude of the burst, which reflects the
actual concentration of active enzyme. kobs is the observed first-
order rate constant for dNTP incorporation, whereas kss is the
observed steady-state rate constant.
Pre-steady state Single Turnover Experiments—To study the
incorporation of the four dNTPs (correct), four different
23-mer DNA primers (Integrated DNA Technologies, Cor-
alville, IA) were 5-end-labeled with [-32P]ATP (PerkinElmer
Life Sciences) using T4 polynucleotide kinase (New England
Biolabs). The primer sequences were as follows: A primer, 5-
CGCGCCGAATTCCCGCTAGCAAT-3; T primer, 5-CCG-
AATTCCCGCTAGCAATATTC-3; G primer, 5-CGAATT-
CCCGCTAGCAATATTCT-3; C primer, 5-GCCGAATTC-
CCGCTAGCAATATT-3. The 5-end labeled primers were
then individually annealed to a 38-mer DNA template (Dhar-
macon Research), 5-GCTTGGCTGCAGAATATTGCTAG-
CGGGAATTCGGCGCG-3. Pre-steady state single turnover
experiments for the incorporation of correct nucleotide were
then measured using excess active RT (200 nM), as determined
by the active site titration, onto TP (50 nM). This ensures single
round/single nucleotide extension at the pre-steady-state level,
for all four dNTPs when using different primers. For studying
the incorporation of incorrect dNTPs (misinsertion), 5-end
32P-labeled T-primer, was annealed onto a 38-mer DNA tem-
plate (see above). Incorporation of incorrect dNTP experi-
ments were carried out manually and at longer time points
ranging from 30 s to 10 min, with higher concentrations of RT
(350 nM). Products were resolved by 14% polyacrylamide-urea
denaturing gel electrophoresis and quantified with the Cyclone
PhosphorImager (PerkinElmer Life Sciences).
Data from single turnover experiments were fitted to a single
exponential equation that measures the rate of dNTP incorpo-
ration (kobs) per given dNTP concentration. This was done by
fitting the data to the hyperbolic equation (Equation 2).
kobs kpoldNTP/Kd dNTP	 (Eq. 2)
From this equation, we could then identify the kinetic con-
stants for each RT during pre-steady state kinetics: kpol is the
maximum rate of dNTP incorporation, and Kd is equilibrium
dissociation constant for the interaction of dNTP with the
EDNA complex.
Cells and Cell Lines
Primary human monocyte-derived macrophage were iso-
lated and differentiated as described previously (16) and were
maintained in culture in RPMI 1640 (CellGro) supplemented
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with 10% fetal bovine serum (HyClone). The primary human
lung fibroblasts (WI-38) were purchased fromATCC and were
cultured in Dulbecco’s Modified Eagle’s Medium (Invitrogen)
supplemented with 10% fetal bovine serum (HyClone) as rec-
ommended. The CHME5 cell line, a human fetal microglial cell
line transformed by SV40 large T antigen, was a gift from Dr.
David Mock (University of Rochester). CHME5 cells were cul-
tured in Dulbecco’s modified Eagle’s medium from Invitrogen
containing 10% fetal bovine serum (HyClone).
Pseudotyped Vector Production and Cell Transduction
The M184I mutation was generated by a PCR-based site-
directed mutagenesis in pD3HIV-GFP as previously described
(16). Vesicular stomatitis virus a protein-pseudotyped HIV-1
vectors, which express eGFP and all HIV-1 proteins except Env
andNef, were produced as described previously (16), and vec-
tors were normalized by p24 levels determined by the HIV-1
p24 antigen enzyme-linked immunosorbent assay system
(Beckman-Coulter). All cell types were transduced with an
equal p24 amount (3 
 105 pg) of either wild-type or M184I
vectors. HLFs and CHME5 cells were treated with 10 g/ml
Polybrene prior to transduction and 24 h post-transduction,
and cells were washed and visualized by fluorescence micros-
copy (Leica), using eGFP as an indicator of transduction effi-
ciency. Following imaging, cells were trypsinized and fixed in a
0.5% formaldehyde solution for further analysis by FACS.
Macrophage were washed after 48 h post transduction and
visualized for eGFP expression at 5 days post transduction. For
FACS analysis, at day 6, cells were trypsinized, fixed, and ana-
lyzed by FACS using the FL-1 channel to detect eGFP expres-
sion. The percentage of transduction was determined using the
CellQuest program (version 3.3, BD Biosciences).
Determination of Cellular dNTP Concentration
The HIV-1 RT-based dNTP quantitation assay was used to
determine cellular dNTP concentrations of WI-38 as previ-
ously described (16). About 1 
 106 cells were used to extract
dNTP samples, which were applied to the dNTP assay. The
dNTP concentrations of macrophage and CHME5 were previ-
ously reported.
RESULTS
Isolation of M184I HIV-1 RT Variants—We isolated 10 RTs
cloned from serum from a single HIV-1 infected patient con-
taining the M184I RT variants, which was kindly provided by
the Multicenter AIDS Cohorts Study (MACS) program. The
amplified RT genes from viral RNAs were cloned directly into
TA cloning vectors, and 10 isolates positive for RT inserts were
sequenced.Among the 10RTclones, threeRTclones contained
theM184Imutation. These three RTs also contained 3–4 other
mutations (T139A, R172K, H198P, and C162A) throughout
their DNA polymerase domain genes. The remaining 7 clones
contain the WT Met residue at the 184 position. We observed
that none of the 10 RT clones were identical in terms of their
nucleotide sequence variations. The amplified RT genes were
then cloned to an E. coli overexpression plasmid. All 10 p66/
p66 homodimer RT proteins, containing a hexahistidine tag
at their N-terminal ends, were purified using Ni2-charged
column chromatography with at least 95% purity as esti-
mated in comparison with purified bovine serum albumin
(99%) by SDS-PAGE.
3TC Resistance of the HIV-1 RT Variants—First, we
attempted to validate the 3TC resistance of the isolated M184I
RT variants using a primer extension assay. A 5 32P-labeled
17-mer primer annealed to a 38-mer RNA template was
employed in this assay (Fig. 1). RT amounts showing approxi-
mately75% full primer extension (“F” in Fig. 1) under stand-
ard primer extension conditions (see “Materials andMethods”)
in the presence of only dNTPs (5 M) were determined, and
then the reactions were repeated in the presence of both 5 M
dNTPs and two concentrations of 3TCTP (7.5 and 125 M).
This assay qualitatively reveals the 3TCMP incorporation capa-
bility of RTs, which results in primer termination specifically at
“G” template sequence positions (Fig. 1). In this assay, all seven
“Met-184 RT” variants displayed significant early termination
of primer extension and reduction of the full-length product to
27–31%, compared with the no 3TCTP control reaction
(75%), in the presence of 3TCTP due to the 3TCMP incorpo-
ration as shown at the positionsmarked as an asterisk in Fig. 1A
with a representative Met-184 Clone 3 RT. In contrast, the
three M184I RT variants did not show significant formation of
the early termination products, and no reduction of full-length
product (70–74%), compared with the no 3TCTP control reac-
FIGURE 1. 3TCTP sensitivity of HIV-1 RT variants. A 32P-labeled 17-mer A
primer (P) annealed to 38-mer RNA template (T) was extended by Met-184
Clone 3 RT (A), M184I Clone 7 RT (B), and I184M revertant of Clone 7 RT (C),
showing75% of primer extension with 5 M dNTPs at 37 °C for 5 min, and
the same reactions were performed in the presence of 5 M of only dNTPs,
and repeated in the presence of both 5M dNTPs and two concentrations of
3TCTP (7. 5 and 125 M). The asterisks indicate termination sites induced by
the 3TCTMP incorporation opposite to the “G” sequences of the template.
The circle indicates RT. F, 38-nucleotide long full-length product. S, unex-
tended 17-mer primer.
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tion (75%), as shown in Fig. 1B with a representative Clone 7
RT, which indicates lower sensitivity (or increased resistance)
to 3TCTP, comparedwith theClone 3RT.Next, to examine the
possibility that other RT mutations found in these M184I RT
variants affect 3TC resistance, we constructed an I184M rever-
tant RT from anM184I RT variant (Clone 7 RT). This revertant
RT contains all the same mutations as the Clone 7 RT variant
except the M184I mutation. As shown in Fig. 1C, like other
Met-184RTvariants (Clone 3RT, Fig. 1A), the I184Mreversion
RT of Clone 7 RT regained sensitivity to 3TCTP (reduction of
the full-length product to 28% from 75% of the no 3TCTP reac-
tion), implying that the M184I mutation is solely responsible
for the 3TCTP resistance of the Clone 7 M184I RT, and other
sequence variations between these RT clones do not signifi-
cantly contribute to the 3TC resistance. Although there is
4–6% less radioactivity in gel C than in gels A and B, this
small difference does not change the interpretation of above
data because there was 250–400% more pausing at the
3TCMP incorporation sites (indicated by an asterisk).
[dNTP]-dependent DNA Polymerization Activity of the RT
Protein Variants—Next, we compared the RNA-dependent
DNA polymerase activity of the 10 RT clones at dNTP concen-
trations observed in HIV-1 target cells. A 17-mer 32P 5-end-
labeled primer annealed to a 38-mer RNA template was also
employed in this assay (Fig. 2). First, RT amounts showing
50% primer extension at 5 M dNTP were determined, and
the identical reactions were repeated with decreasing dNTP
concentrations (1, 0.25, 0.1, and 0.05 M). All of the seven RT
variants containing Met at position 184 displayed efficient
primer extension even at 0.05 M dNTP (see Clone 3 RT of Fig.
2A as a representative clone of the Met-184 RT variants). In
contrast, the M184I RT variants showed significantly reduced
RT activity at lower concentrations such as 0.25, 0.1, and 0.05
MdNTP, as shown byClone 7 RT in Fig. 2A as a representative
clone of the M184I RT variants. The RT variants containing
M184I displayed reduced polymerization activity at the low
physiological dNTP concentrations where the Met-184 RT
variants still efficiently synthesize DNA.
We also employed M184V HIV-1 RT protein in this test. As
shown in Fig. 2B, M184V RT exhibited higher than 50% of the
Met-184 Clone 3 RT activity even at low dNTP concentration,
whereas the M184I Clone 7 RT showed more severe activity
reduction at these low concentrations compared with theMet-
184 Clone 3 RT as well as the M184V RT protein. Note that all
10 RT variants showed similar specific activity at the highest
dNTP concentration tested (5 M), and the I184M reversion
also displayed efficient primer extension in both high and low
dNTP concentration. In addition, the I184M revertant gained
the Met-184 RT-like high activity at the low dNTP concentra-
tion (data not shown).
Pre-steady-state Kinetic Analysis of M184I and Met-184 RT
Variants—Because two previously characterized RT muta-
tions, Q151N and V148I, that specifically reduce the dNTP
binding affinity, also render reduced RT activity specifically at
low dNTP concentrations (16, 23, 29), we examined the Kd and
kpol values of the M184I-containing RT variants, using pre-
steady-state kinetic analysis. For this kinetic analysis, we chose
one of the three M184I clones (Clone 7 RT) and one Met-184
RT clone (Clone 3 RT) as well as the I184M reversion RT pro-
tein of the M184I Clone 7 RT. First, we determined the active
concentrations of the three HIV-1 RT proteins on a 32P-labeled
23-mer (T-primer), annealed to a 38-mer DNA template
(T-primer-template) as described previously (22). We meas-
ured product formationwhen 800MdTTPwasmixedwithRT
(150 nM, protein concentration as determined with a Bradford
assay), prebound onto theTP (300 nMTP). Therewas an initial
burst of product formation due to dTTP incorporation onto the
prebound RTTP complex (pre-steady-state kinetics), which
was followed by a slower and linear phase of product formation
corresponding to the steady state kinetics associated with mul-
tiple rounds of DNA polymerization (Fig. 3). Our active site
titration analysis revealed that the active site concentrations of
RT variants Met-184 clone 3, M184I clone 7, and I184M rever-
tant proteins were all 30–50% (I184M RT data not shown).
The slope of the burst phase is termed kobs (rate of DNApolym-
FIGURE 2. dNTP concentration-dependent reverse transcription activity
of HIV-1 RT variants. A, a 32P-labeled 17-mer A primer (P) annealed to a
38-mer RNA template (T) was extended byHIV-1 RT variants, Met-184 Clone 3
RT,M184I Clone 7 RT, andM184V RT showing50%of primer extensionwith
5M dNTPs at 37 °C for 5min, and the reactions were repeatedwith decreas-
ingdNTP concentrations (lanes 1–5: 5, 1, 0.25, 0.1, and 0.05M). B, the%of the
fully extended product (F) in each lane was calculated, and the % extensions
at lower dNTP concentrations were normalized with that at 5 M (lane 1) for
each RT protein. Then, the ratios of the normalized % extensions between
Met-184 Clone 3 RT and the other two RTs (open circles, M184I Clone 7 RT;
black diamond, M184V RT) at each dNTP concentration were plotted and
standard deviations in triplicates were15%.
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erization during the pre-steady state), and the slope of the sec-
ond phase is termed kss (rate of DNApolymerization during the
steady state). The pre-steady state rates of dTTP incorporation
onto theTP (kobs) for theMet-184Clone 3,M184IClone 7, and
I184M revertant RTwere 39 17, 68.8 16, and 168 21 s1,
respectively, and their rates during the steady state were 8.1

101 6
 101, 3.7
 101 8
 102, and 7
 102 2

102 s1, respectively (Fig. 3).
Next, we performed single turnover experiments (200 nM
active RT and 50 nM TPs) to obtain an actual measurement of
the dNTP incorporation rate at different dNTP concentrations
during the pre-steady state. Bymeasuring reaction rate (kobs) as
a function of dNTP concentration (Fig. 4 for dTTP incorpora-
tion), we were able tomeasure the kinetic parametersKd, or the
binding affinity of RT to the incoming nucleotide substrate, and
kpol, the maximum rate of dNTP incorporation (conforma-
tional change and chemical catalysis). The pre-steady state
kinetic data for RT variants are summarized in Table 1. The
dNTP binding affinities (Kd) of M184I RT Clone 7 RT variant
for dNTPs were 50–86 M, and the chemical catalysis (kpol)
valueswere 51–124 s1. For thewild-type-likeMet-184Clone 3
RT variant, Kd values were comparatively lower, 4.2–9.5 M,
indicating high affinity for the incoming dNTP substrate, how-
ever the kpol values, which were 52–88 s1, were similar to
those of M184I RT Clone 7 variant. These kinetic values of the
Met-184Clone 3 RT are very similar to those of anHIV-1 strain
HXB2 RT that was previously characterized (17). This kinetic
study indicates that M184I RT Clone 7 has 10- to 13-fold lower
dNTP binding affinity for the incoming dNTPs, compared with
that of Met-184 Clone 3, while these two RTs have similar
incorporation capability (kpol). The pattern of the kinetic differ-
ence observed between Clone 3 and Clone 7 RTs is identical
with that observed between WT HXB2 RT and Q151N (and
V148I) dNTP binding HIV-1 RT mutants (22, 29).
We also performed single turnover kinetics for dTTP incor-
poration for the I184M revertant on the same TP. This rever-
tant was cloned using the same background as M184I RT, and
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FIGURE 3. Active site titration for RT variants. Pre-steady and steady-state
kinetics of Met-184 Clone 3 RT (A) and M184I clone 7 RT (B) incorporating
correct dTTP onto the 32P-labeled 23-mer T primer annealed to the 38-mer
templatewere analyzed. Reactionswere carried out at the indicated times by
mixing together a solution of RT (150 nM, protein concentration) prebound to
TP (300 nM) to a second solution with 800 M dTTP under rapid quench
conditions (see “Materials and Methods”). The data were fit into the burst
equation as indicated by the solid line, which provides ameasure of the active
concentration of RT (A), the observed first order rate constant for the burst
phase (kobs) and the first order rate constant for the linear phase (kss) for
Met-184 Clone 3 and M184I clone 7 RT. The pre-steady-state rates of dTTP
incorporation onto the TP (kobs) for the Met-184 clone 3 and M184I clone 7
RTs were 39  17 and 68.8  16, respectively, and their rates during the
steady state were 8.1 
 101  6 
 101 s1 and 3.7 
 101  8 
 102,
respectively.
(A) M184 Clone 3RT
0
0 .01
0 .02
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0 5 1 0 1 5 2 0 2 5 3 0
[d T T P ] u M
(B) M184I Clone 7 RT
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FIGURE4.Pre-steadystatedTTP incorporationbyMet-184clone3 (A) and
M184I clone 7 (B) RTs. The 32P-labeled 23-mer T primer annealed to the
38-mer template (50 nM) was extended with excess RT (200 nM, active site
concentration) for single round of dTTP incorporation at five different dTTP
concentrations. These data were used for the determination of Kd and kpol
values of the in vivo RTs illustrated in Table 1.
Altered dNTP Interaction ofM184I HIV-1 RTMutant
APRIL 4, 2008•VOLUME 283•NUMBER 14 JOURNAL OF BIOLOGICAL CHEMISTRY 9211
 by guest on A
ugust 22, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
the only difference between the two RTs is at position 184. As
shown in Table 1, similar to Met-184 clone 3 RT, the I184M
revertant showed a higher dNTPbinding affinity for the incom-
ing dNTP substrate, 6.7 M, compared with 56 M for the
M184I Clone 3 RT variant. The kpol values were also similar to
that ofMet-184 Clone 3 RT andM184I Clone 7 RTs, indicating
that the reducedKd ofM184I RT is likely due to themutation of
Met to Ile at position 184 of Clone 7 HIV-1 RT.
Cellular dNTP Concentration-dependent Infectivity of HIV-1
Harboring M184I RT Mutant—We previously reported that
human macrophages, which are a key HIV-1 non-dividing tar-
get cell type, contain extremely low dNTP concentrations
(20–40 nM), compared with other dividing cell types (16).
Therefore, based on our results with the dNTP concentration-
dependent polymerization assay, we hypothesized that an
HIV-1 vector containing the M184I mutant RT showing
reduced DNA synthesis at low dNTP concentrations may not
be able to support reverse transcription and, therefore, fail to
infect macrophage. To test this hypothesis, we employed an
HIV-1 vector system expressing eGFP and three cell types con-
taining different levels of dNTP concentrations: primary
human macrophage, WI-38 HLFs, and human transformed
CHME5 cells. Our dNTP quantitation assay showed that HLF
and CHME5 cells have 200–400 nM and 3–4 M dNTPs,
respectively (Fig. 5B).We transduced these three cell typeswith
an equal p24 level of wild-type and M184I vectors, and the
transduction efficiency was determined by fluorescent micros-
copy and FACS analysis for GFP expression of transduced cells.
As shown in Fig. 5 (A and B), wild-type HIV-1 vector efficiently
transduced all three cell types. In contrast, the vector contain-
ing the M184I mutant failed to transduce macrophage even
though thismutant vectorwas still capable of transducingHLFs
and CHME5 cells containing higher levels of dNTP concentra-
tions than macrophage. This result supports the idea that the
M184I RT mutant will fail to support efficient proviral DNA
synthesis inmacrophage containing very low dNTP concentra-
tions, as demonstrated in the biochemical experiments
described in Fig. 2A. Interestingly, the M184I vector showed
50% of wild-type vector transduction efficiency in HLF,
whereas this mutant vector showed
100% of the wild-type vector level of
transduction efficiency in CHME5
cells containing higher dNTP con-
centration than HLFs. The 50%
transduction efficiency of M184I
vector in HLF suggests that the
M184I mutant RT still cannot fully
support reverse transcription at the
dNTP concentrations found in HLF
(200400 nM), which are lower
than those found in CHME5 cells.
These data are consistent with the
biochemical data described in Fig.
2B showing that M184I RT displays
only 50% of Met-184 Clone 3 RT at
0.25 M dNTP. More interestingly,
it was reported that, unlike M184I
virus, M184V virus is able to infect
macrophages (30, 31), and this
observation is consistent with our
biochemical data illustrated in Fig.
2A that M184V RT still maintains
RT activity at least 50% of the wild-
type RT activity even at low dNTP
concentrations found in macro-
phages. Overall, these vector data
CHME5Human Lung Fibroblasts(A) Macrophage
Wild Type         M184I Wild Type        M184I Wild Type        M184I    
BF
GFP
Human 20~40nM 17+1.7 >1+0.06 
(0.5%)macrophage 
M184I vector 
% of transduction 
(% to wild type) 
Wild type vector 
% of transduction 
dNTP 
concentration 
Cell Type 
51+4 
(100%) 
48+2 1.5~3.2µMCHME5
32+3 
(55%)
58+2 150~340nM Human lung 
fibroblast 
(B)
FIGURE 5. Transduction of HIV-1 vectors containing wild-type and M184I RTs in human cell types.
A, human macrophage, HLFs, and CHME5 cells were transduced by an equal p24 amount (3 
 105 pg) of
wild-type and M184I HIV-1 vectors. eGFP expression of transduced cells was analyzed after 6 days for macro-
phage and after 24 h post-transduction for HLF and CHME5 cells by fluorescencemicroscopy. Both bright field
(BF) anddark field (GFP) images are shown.B, the average transduction efficiencyof duplicatedexperiments, as
determined by FACS for GFP expression, and the transduction efficiency ratios between wild-type and M184I
mutant vectors as well as cellular dNTP concentrations of each cell type are summarized. The dNTP concentra-
tion of macrophage and CHME5 cells was previously reported (16, 24).
TABLE 1
Pre-steady-state parameters of HIV-1 Clone 3 and 7 RT variants
DNTP
substrates HIV-1 RTs
Kinetic parameters
(-fold differences)a
Kd kpol kpol/Kd
M s1 M1 s1
M184 7.2 3.2 57.5 9.4 8
dGTP Clone 3 RT (
1) (
1) (
1)
M184I 64 5.7 51 8 0.8
Clone 7 RT (
9) (
0.8) (
0.1)
M184 4.8 1.8 52 5.8 10.8
dATP Clone 3 RT (
1) (
1) (
1)
M184I 50 4.5 84 2 1.7
Clone 7 RT (
10) (
1.6) (
0.15)
M184 9.5 2.1 88 7.5 9.3
dCTP Clone 3 RT (
1) (
1) (
1)
M184I 86 9.7 124 39 1.4
Clone 7 RT (
9) (
1.4) (
0.16)
M184 4.2 2.2 63 12 15
dTTP Clone 3 RT (
1) (
1) (
1)
M184I 56 7.5 56 3 1
Clone 7 RT (
13) (
0.8) (
0.06)
I184M 6.7 2.2 79 8 11.8
Revertant RTb (
1.5) (
1.25) (
0.8)
a The -fold differences are shown for M184I Clone 7 RT relative to M184 Clone 3
RT.
b The I184M revertant is the same as M184I Clone 7 RT except for the Ile-184
residue.
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are consistent with previous reports thatM184I HIV-1 variants
isolated during 3TC therapy displays greatly reduced infectivity
in human macrophage (32, 33).
StructuralComparison of the PolymeraseActive Sites ofWild-
type and M184I HIV-1 RTs—Finally, because the pre-steady-
state kinetic data described in Table 1 demonstrate the reduced
dNTP binding affinity of M184I RT, we attempted to compare
themolecular shapes of the polymerase active sites in wild-type
andM184I mutant RT proteins. For this, as shown in Fig. 6, we
employed three separate structures of HIV-1 RT previously
reported: 1) ternary complex of wild-type HIV-1 RT (WT
RTTPTTP) (34), 2) binary complex of wild-type HIV-1 RT
(WT RTTP) (35), and 3) binary complex of M184I HIV-1 RT
(MI RTTP) (8). We removed the TPs in these structures for
better visualization of the dNTP binding pocket and the posi-
tion of residue 184 (gray area of Fig. 6). The ternary complex of
WT HIV-1 RT (Fig. 6A with TTP and Fig. 6B after removing
TTP) allows us to visualize the surface and shape of the HIV-1
RT dNTP binding pocket. However, because the dNTP sub-
strate targets the dNTP binding pocket of the binary complex
(RTTP) during the formation of the ternary complex
(RTTPdNTP) that is capable of catalyzing the chemical reac-
tion, we compared the molecular shapes of the more relevant
binary complexes of the WT (Fig. 6C) and M184I (Fig. 6D)
HIV-1 RTs. Unlike the wild-type residue, the Ile mutation indi-
cated by the solid arrow in Fig. 6D exposes its larger/rigid
-branched side chain toward the dNTP binding site. It is plau-
sible that this larger side chain of
M184I restricts the entry of dNTP
substrates from the solution into the
dNTP binding pocket, resulting in
the reduction of dNTP binding
affinity. Furthermore, it can be
clearly observed that the shape of
the M184I dNTP binding pocket
(Fig. 6D) appears to be widened,
compared with that of the WT RT
(Fig. 6C, see double-headed dotted
arrows). This altered dNTP binding
pocket of the M184I mutant may
also explain its reduced ground state
dNTP binding, compared with the
WT RT.
DISCUSSION
Met-184 in HIV-1 RT is the sec-
ond residue of the highly conserved
YXDD motif that defines the poly-
merase active site of retroviral
reverse transcriptases (36). The
YXDDmotif makes an unusual type
II -turn that allows the side chains
of the four residues to make con-
tacts with the template primer,
metal cofactors, and dNTPs (8).
Lentiviral RTs, includingHIV-1 and
SIV RTs, contain Met at the X posi-
tion in the YXDD motif, whereas
RTs of other groups of retroviruses (e.g.MuLV, a -retrovirus)
mainly contain Val (YVDD) (37, 38). However, two mutations
at the Met residue of HIV-1 RT, M184I and M184V, arise dur-
ing the treatment of the RT inhibitor 3TC (lamivudine) render-
ing viral resistance to 3TC. Structural analyses suggest that the
mechanism of resistance to 3TC of M184V and M184I muta-
tions is a result of the steric hindrance between the -branched
amino acid side chains of the Val and Ile mutations and the
unnatural () enantiomer sugar structure of 3TC (8, 9).
These 3TC resistance mutations confer several additional
enzymatic alterations to HIV-1 RT. One such alteration is
reduced viral DNA polymerization (32). Although a less signif-
icant difference was observed between viral replication kinetics
of wild-type and 3TC resistant HIV-1 viruses in tissue culture
infection of a T-cell line, the 3TC mutant viruses displayed
delayed replication in the culture with peripheral blood mono-
nuclear cells (32, 33). Gel analysis of reverse transcription prod-
ucts revealed that the 3TC-resistant mutants make shorter
DNAproducts indicating their reduced processivity, compared
with the wild-type RT. It is likely that this processivity reduc-
tion will be more pronounced under the environments of pri-
mary cells, whose dNTP concentrations are much lower than
those of the transformed cell lines. In fact, intracellular dNTP
levels vary significantly between different cell types and fluctu-
ate during the cell cycle (39). Another enzymatic alteration is
that both M184I and M184V showed higher fidelity compared
with wild-type RT (13–15, 40).
(A) WT ternary complex with TTP
(D) M184I binary complex(C) WT binary complex
(B) WT ternary complex without TTP
FIGURE 6. Comparison of the active site structure of wild-type and M184I HIV-1 RTs. A, the active site
structure of thewild-type RT ternary complexwith TTP (RTTP-TTP (34)) and B, the same structure after remov-
ing TTP, which allows us to visualize the surface and shape of the dNTP binding site. C, the binary complex of
wild-type HIV-1 RT (RTTP (35)) and D, M184I RT (8). The residue 184 of each structure was labeled in gray. The
larger -branched side chain of the M184I binary complex (D) was marked with a thick arrow, and the dNTP
binding space was marked with a dotted double-headed arrow. The TPs in these structures were removed for
better visualization of the dNTP binding pocket of each structure.
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The dNTP binding and template-primer interaction are
two major mechanistic determinants for the processivity of
DNA polymerase, which is defined as the number of nucle-
otides incorporated per single round of the primer extension
(41, 42). Under saturating dNTP conditions, the RTTP
interaction becomes a major factor for the RT processivity.
In contrast, with limited dNTP substrates, HIV-1 RT likely
stalls more frequently due to kinetic interference throughout
the template sequences, and this can promote a higher prob-
ability of HIV-1 RT falling from the template, further
restricting processive DNA synthesis (43). Even at relatively
high dNTP concentrations where wild-type RT efficiently
synthesizes DNA, RT mutants with reduced dNTP binding
affinity likely exhibit distributive DNA synthesis due to dis-
rupted DNA polymerization kinetics. This was observed
with the Q151N- and V148I-reduced dNTP binding mutants
of HIV-1 RT (22). We present kinetic evidence that, unlike
M184V HIV-1 RT (12), the M184I mutation significantly
reduces the binding affinity of HIV-1 RT to normal dNTP
substrates without altering the kpol step. Indeed, the accom-
panying report (48) confirmed that M184I RT displays
reduced processive DNA synthesis capability specifically at
low dNTP concentrations. Moreover, the processivity defect
was eliminated at saturating dNTP concentration, indicating
that the effect of theM184I mutation on dNTP binding is the
sole cause of the processivity defect.
In this study, we examinedM184IHIV-1 RT variants directly
isolated from a serum sample from an HIV-1 infected patient
containing both M184I and Met-184 RT (wild-type like) vari-
ants, provided from theMACS program. TheMet-184 RT vari-
ants isolated in the same serum sample were used for mecha-
nistic comparison with the M184I RT variants. Due to the
typical genetic hypervariable nature of HIV-1, no RT variants
cloned from this single serum sample (among 10 clones) were
genetically identical, and even among the threeM184I RT vari-
ants, unique individual and/or combinations of other muta-
tions were observed throughout their RT genetic sequences.
The heterogeneous genetic backgrounds of individual RT
clones can make it difficult to claim the role of a particular
mutation or residue of interest to an overall RT phenotype. To
minimize this difficulty, we constructed an I184M revertant RT
of a representativeM184I RT isolate (Clone 7 RT) and used this
RT construct to study the specific enzymatic alterations made
by theM184Imutation in these genetically varying RT variants.
Only theM184Imutation inClone 7 RTwas reverted to I184 by
site-directed mutagenesis. Other mutations within this clone
remain unchanged, and the entire RT region of the revertant
was sequenced to confirm that other mutations of the original
Clone 7 RT remained intact in the revertant. As expected, the
I184M reversion RT protein displayed identical enzymatic
properties with the Met-184 RT clones (i.e. Clone 3), including
1) similar 3TC sensitivity, 2) high dNTP utilization efficiency
and 3) tight dNTP binding affinity. This implies that other
mutations contained in the Clone 7 RT variant do not signifi-
cantly contribute to the biochemical alterations of the M184I
mutation observed in this study. Consistentwith previous stud-
ies, we also observed that theM184I Clone 7 RT variant showed
a higher fidelity compared with Met-184 clone 3 RT.4
Finally, we attempted to elucidate how the M184I mutation
restricts the dNTP binding of HIV-1 RT by comparing the
active site structures of the binary complex form (RTTP) of
wild-type andM184IHIV-1 RTs, whichwere previously solved.
Previous structural analysis suggested that the two -branch
amino acidmutations (Val and Ile) at position 184 of HIV-1 RT
introduce more rigid side chains to the active site, compared
with the wild-typeMet residue. The rigid side chains of the Val
and Ilemutations occupy the space that is normally occupied by
the L-form sugar moiety of the 3TCTP, which leads to the
restricted binding and resistance to 3TCTP (8, 9). It was also
demonstrated that the side chain of the M184I mutation also
alters the RT interaction with the template nucleotide, which
was used to explain the decreased processivity of theM184I RT
(8). Interestingly, however, recent pre-steady-state kinetic anal-
yses of M184V RT demonstrated that, unlike the M184I muta-
tion, theM184Vmutation did not significantly affect binding as
well as chemical catalysis of HIV-1 RT to normal dNTPs, sug-
gesting that -branched side chain of the M184V mutation
minimally affects the RT interaction with normal dNTP sub-
strates (12).
As shown in Fig. 6D, in addition to sterically hindering entry
of 3TCTP, the longer and rigid -branched side chain of the
M184I mutation appears to expose its long and rigid side chain
toward the dNTP binding pocket, which can restrict the entry
and binding of the incoming dNTP substrate (Fig. 6D). It is
plausible that the direction and position of the incoming dNTP
during entry into the dNTPbinding pocket varies depending on
the sequence of the template. This is supported by a wide range
of dNTP incorporation kinetic variations during DNA synthe-
sis with heterologous template sequences (12, 44, 45). There-
fore, the proper space of the dNTP binding pocket of HIV-1 RT
likely accommodates efficient entry and uniquely tight binding
of dNTP substrates in the active site of HIV-1 RT, and this can
facilitate the efficient DNA synthesis rate during reverse tran-
scription with heterologous sequence templates such as the
viral RNA genome evenwith limited dNTP pools found in non-
dividing cells (i.e. macrophage). Because the M184V RT
showed very similar dNTP binding affinity with WT RT, the
interruption of dNTP entry into the dNTP binding pocket by
the M184I mutation might not occur in the M184V RT with a
shorter -branched side chain (12). In addition, as displayed in
Fig. 6 (C and D), the dNTP binding pocket of the M184I RT
seems to be open more widely than that of WT RT, and,
together with possible limited entry of dNTP, the deformation
of the M184I dNTP binding pocket (Fig. 6D) may also contrib-
ute to destabilizing the ground state dNTP binding affinity of
Met-184 RT.
Various virological studies have reported the instability of
theM184I mutation using both tissue culture and animal mod-
els. The M184I mutant virus shows more attenuated viral rep-
lication kinetics than M184V virus or WT virus in peripheral
4 V. K. Jamburuthugoda, J. M. Santos-Velazquez, M. Skasko, D. J. Operario, V.
Purohit, P. Chugh, E. A. Szymanski, J. E. Wedekind, R. A. Bambara, and B.
Kim, our unpublished data.
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blood mononuclear cells even though the M184I virus effi-
ciently grows in established Sup T cell lines (32). The cellular
dNTP concentration difference between peripheral blood
mononuclear cells and Sup T cells was a suspected reason for
the failure of the M184I mutant virus in peripheral blood
mononuclear cells. This observation is consistent with our vec-
tor data described in Fig. 6. Indeed, the M184I vector, which
efficiently transduced both HLF and CHME5 cells containing
relatively higher dNTP concentrations, failed to transduce
macrophage containing very low dNTP concentrations. Unlike
the conditions of pre-steady-state Kd measurements, viral rep-
lication occurred in the steady state, where RT executed multi-
ple rounds of DNA synthesis. Therefore, the steady-state DNA
synthesis described in Fig. 2 is more relevant for addressing the
effects of RTmutations on viral replication kinetics. M184I RT
was still highly functional at 1 M. Because viral replication
occurred over a long time period (6–12 h),M184I RTwas likely
to complete proviral DNA synthesis even at 0.3 M dNTP
(HLF) as well as 1–3 M (CHME5). The virological alteration
made by the M184I RT mutation can be explained by our
kinetic data that M184I RT has reduced dNTP binding affinity
and reduced RT activity at low dNTP concentrations. As dis-
cussed above, themore significantly reduced RT processivity of
M184I RTwas suspected to be responsible for the reduced rep-
lication kinetics of theM184I virus. SIV has also been shown to
develop very similar 3TC resistance profiles as HIV-1 (46). The
pathogenesis of the SIV M184V variant is characterized in a
macaquemodel (SIVmac239) (47).When theM184Vmutation
was maintained in animals treated with 3TC, the M184V SIV
still induced a pathogenesis profile very similar to wild-type
SIV. Interestingly, the M184V mutation quickly disappeared if
the animals infected with the M184V virus were not treated
with 3TC, suggesting that the M184V SIV is less fit than wild-
type SIV. However, the pathogenesis in vivo of the M184I virus
has not been characterized.
This study presents a line of biochemical evidence that,
unlike the M184V mutant, the M184I mutant has reduced
dNTP binding affinity, and this kinetic alteration may result
from the interruption of the dNTP entry to the dNTP binding
pocket. The reduced dNTP binding affinity of M184I RT,
togetherwith the altered interactionwith template nucleotides,
can synergistically restrict processive DNA synthesis under
physiological dNTP concentrations, and these alterations
caused by the M184I mutation could be mechanistic elements
that contribute to the in vivo instability of the M184I mutation
and its rapid conversion to M184V.
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